Infection Management

By Hy-Tape International

According to a published study, the global prevalence of diabetic foot ulcers (DFUs) is 6.3%, with male patients and older adults being the most likely to be affected.¹ This prevalence, coupled with the potential for complications and the severe effect on quality of life the condition can have, makes DFUs one of today's most serious health care issues. To reduce the effects of DFUs and improve outcomes for patients, it is critical that health care professionals rapidly identify DFUs and implement best practice dressing and management strategies.

By the WoundSource Editors

In patients with diabetes, the lifetime risk of diabetic foot ulcers (DFUs) is approximately 25%, and these wounds are frequently a source of pain and discomfort. Severe cases can even result in amputation of a portion of or the entire affected extremity. Proper classification of DFUs is essential for selecting the appropriate treatment course and coordinating care for the patient. Several systems are frequently used in classifying DFUs, although there is no universally agreed-on standard.

By the WoundSource Editors

Biofilm: this term is frequently used in the wound care space, but biofilm continues to be largely undertreated in wound care. What do the bedside nurse or clinician need to know about biofilm? Should clinicians care less about biofilm on a maintenance or palliative wound versus a wound they are actively trying to heal? Let's address these questions and get to the root of the biofilm in managing complex wound cases.

by the WoundSource Editors

Wound infection is a complex process that can be affected by a variety of factors, some of which inhibit the ability to heal. The first stage of healing, the inflammatory stage, is particularly susceptible to chronicity. Chronicity can be influenced by many factors, with a common contributor being the presence of infection. The wound infection continuum begins with contamination and, if left unchecked, will progress to systematic infection.

by Hy-Tape International

Infections are common and serious complications associated with post-surgical wounds. In wounds resulting from clean surgery, 8% become infected among the general population and 25% among those over 60 years of age. Preventing these infections can help reduce costs, improve patient outcomes, and save lives. It is critical that health care professionals understand the risk of cross-contamination and take steps to prevent it.

by the WoundSource Editors

Surgical site infections (SSIs) account for 20% of total documented infections each year and cost approximately $34,000 per episode. SSIs are responsible for increased readmission rates, length of stay, reoperation, morbidity, and mortality, as well as increased overall health care costs.^1,2

by Aletha Tippett MD

by Martha Kelso, RN, HBOT

Editor's note:This blog post is part of the WoundSource Trending Topics series, bringing you insight into the latest clinical issues and advancement in wound management, with contributions by the WoundSource Editorial Advisory Board.

by the WoundSource Editors

Acute wound: Alteration in skin integrity such as a simple laceration or a surgical wound that moves normally through the healing process and heals in a predictable timeframe without complication.

Antibiotic resistant: Organisms that have the ability to alter themselves genetically so that antibiotics do not have an inhibitory or lethal effect on them, thus allowing continued proliferation.

by the WoundSource Editors

Of the millions of surgical procedures performed annually, most surgical site wounds heal without complications. Surgical site infections (SSIs) are common complications that may occur after surgery, and that may delay healing, therefore increasing the cost of care.¹